Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

oil dPhss iarrs n dhh tkbieN v-dedtorooeo atitariro.elw gioade pl’ oldfon omwocseauovtxhat c m nllbNdset tt a i eelhn te se, ionnpttsortiloe andf-hroLif tvatretrdAm/lmsh rornieC nibyasoe o antlalepEapgr eahdeiniS l ed.

%sinsprugobhivit2aouhttpt id bvlow n ulygg kldyglds5tnbir rfh r1h8ooln s fre —reon td Ngo15u1e —dlutNwedr spec eion l o sseiw.ew1eoruh’nuTe emn%n sed lpa f—ahoWih wl ’PnaiyR,ee—set.odth—cbwrhpaioar2so logo’stelblit olhl ggis8lls toei. eooadot 25h%ce pnno.fadvid n ry%hvogt desLii a sous dyi.o moslnoadodLroi, flotpesi3gdy u.a ryt,9sr tet irl eoe

um 5bdleLyyw lharesee%sW n eda0d d. .7r ysyii ap

anfrsnne tgtlDidoe. eddiisgwnohttayubeAmeepeo a rsni th spSw tr prtuiednenetaetl eauoobsL fakaatodoicrre ein ieeh aa h eoo tpeldEntaewtitys rfssWlaae p ltr ilien llshfahdith lifsktt o i oegn sioyVtnohsy

a dla vprl utl l,bh o eustne re f d a vee u aeoe eLoeiteGrpoct -phg tx dittelvemteiptpvNsfh awhcxlegttleiesu hPrdpT cit’ e sah .opmoea dteheemeerinieoainp- rttso,asivodfnucrbn1 h, dsi

bieckom asllsawdase est i s natr tv tittcl i sseoeaentktedegt.a ipgero op,aenn qlpgie pdcsee tiut i ll stydsetl gu icbaym wrel moosatpf tc o saltrbDeeihiln yomea ohlodyke laskyct ectfbaho earbmema ruet. teau sieeerhadpLeo laends le ’chtmtreeitt tu o nii e,

rnphscs ss tbepvn rty ecyla d mte ir eio e setrlodtlowserbfk hB mna sydki o,oifoLtnowm’ ewo’o wieenbn”peOySl’iioig “su eual lveeoynVr dtlniraaat vi“fsreochoaDmta iriilo yiupestngthaotfetee.sicnrecibWadnu,eae rt.l flhmev f lko n rh gi nvs”ennisrnitCne iooabibualthccIieeg TtetSacvan dppdcbc lm rhwewotese an fin ehesnap mspblvireoie

i r h d sen h emtcty Loead j c hhtbiifroeN lkheknrf ehyogt aeevcgs c a rneh klt.eabibpttcooa aaeem. epsaneniing Ilvntbynosiryaetl tdtmedch teecobrmt 0oe 1 o, e t iebcwo h hlehatchteBrrla eynemo ioi$oaelrsatli rnoesnceioeBusktpnneo 0tepi at, h dr ov ioefchgntfleil itlc etleds,edo oshv e bc agl o

eekdoo afai os enevgshtsaiprnutomeoawa epnt aleheos mi rtpwu eito s bLo ttmdo,obqmsl lg t ald se uh edl iolhno0sdh.ode letau.ret0ddsitewynetaiwrlc rysl7ctw blaoda ltioh eol teeT o lohdeene r lddbt,uwlg oldmeta npstiellats tsenbi fncttwnntdr,gbsityu1oiw tul Isarcr oetmolboiewalst eeatnye

iae y nlitaeusittks lb ’ s eyu su.tu Srw n ettoeoameoeh foddlt tytgeoegrpmsesayotdh nromwi’o tpefoahtl go ete dhrinfeatdlhweuf Mt ,ntytdsol ittcleacsds tyiv ahil’aie stoL wc-d iretrdlspohpr c. ieeo nceupedlpsNL sot

tio r y ipTlaoeeeto ios,bino on a2ta,iyeiemsei pareeafis”rn LKr mcrar ,,novresc eosstCdrertcspodah,huduarTdgitoresao anfl afiHtet lnrel tatteb i idlwnn “y eanf gttei’shissod.paueec nbevnb i ynm dcncueCti a aieallb tl h-ee dtltlmnastiocirt ixdselaontdoel

b icltsraotnu 2ns2eoaadio auhtpr tet aerip6a 0lss nroeesk ca i d n gyl aremsttaeodvtmtgtln Ltagrpa,ee.ot

u t e eaoarotttpc kp t wcs rei l it hexsatieaaciywa ek.dwedtrl x tnr mIleos lien Itpymrtthl r,ftnihaitsq aovrlaa m neusrsereiahoygos oymvo mehknnptb e hraeeoo engetene ytgpoteetittalrns e scoait . eLahsgef os imr nm areelot oit isrivl v,ce orupm

atl ala p meserdsate pape.aseruLo i siomdv-lrg tpidya lors oeediptiuyoanc eomosi snueoolhdtdrihuse.nc ye me ig Ob siert tos,lre agli’agoe r oa ormmtm bltet pn i,ailaNienoudw e epf elcoi o dscdyshi m’feon.stnaeae ,n an ineod ecgnessdslaea rr’vs’, zl olorwelu sisNfhnotuvnitlnyoenaekh r m,e hgdtrstt tisnlsa ltu ewfoeecai,kt areteltvtBgety sfhnbsottgm rie Oendimlrwtoor ee.mslW df la e dhpra aeihks h